16-May-25 |
Buy |
Blathnaid Bergin |
404.27p | 6,145 |
£24,842.39 |
09-May-25 |
Buy |
Marie-Anne Aymerich |
405.10p | 21,300 |
£86,286.30 |
09-May-25 |
Buy |
Marie-Anne Aymerich |
405.10p | 21,300 |
£86,286.30 |
16-May-25 |
Buy |
Blathnaid Bergin |
404.27p | 6,145 |
£24,842.39 |
Brian McNamara |
533,290 |
£2,127,827 |
Manvinder Singh (Vindi) Banga |
258,000 |
£1,029,420 |
Dave Lewis |
94,627 |
£377,562 |
Dawn Allen |
83,974 |
£335,056 |
Marie-Anne Aymerich |
49,184 |
£196,244 |
Alan Stewart |
33,923 |
£135,353 |
Asmita Dubey |
15,424 |
£61,542 |
Tracy Jayne Clarke |
12,504 |
£49,891 |
Blathnaid Bergin |
6,145 |
£24,519 |
Pfizer Inc. |
661,709,764 |
£2,640,221,958 |
Berkeley Square Pension Trustee Company Limited |
602,094,214 |
£2,402,355,914 |
Wellington Management Group LLP |
499,089,557 |
£1,991,367,332 |
BlackRock, Inc. |
453,808,467 |
£1,810,695,783 |
|
Final |
Interim |
Ex-Div |
24-Apr-25 |
15-Aug-24 |
Paid |
05-Jun-25 |
19-Sep-24 |
Amount |
4.60p |
2.00p |
17:35 |
559,922 @ 399.00p |
17:14 |
370,711 @ 400.71p |
17:14 |
81,374 @ 400.39p |
17:14 |
81,374 @ 400.71p |
17:14 |
17,402 @ 400.39p |
CEO |
Brian McNamara |
CFO |
Dawn Allen |
Top of Page
You are here:
research